Hattersheim, Germany

Walter Dürckheimer

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Dürckheimer. Retrieved from https://idiyas.com/inventor/walter-danduumlrckheimer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Dürckheimer: Innovator in Corticoid Research

Introduction

Walter Dürckheimer is a notable inventor based in Hattersheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of corticoid compounds. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Dürckheimer holds a patent for "Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds." This patent highlights his expertise in the synthesis and application of corticosteroids, which are vital in treating a range of conditions.

Career Highlights

He is currently associated with Aventis Pharma Deutschland GmbH, where he continues to advance his research and development efforts. His work at this prominent pharmaceutical company has allowed him to contribute to innovative solutions in medicine.

Collaborations

Dürckheimer has collaborated with esteemed colleagues such as Ulrich Stache and Hans-Georg Alpermann. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical industry.

Conclusion

Walter Dürckheimer's contributions to corticoid research exemplify the vital role of inventors in advancing medical science. His innovative work continues to impact the field of pharmaceuticals positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…